Deprivation and mass screening: Survival of women diagnosed with breast cancer in France from 2008 to 2010.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
06 2019
Historique:
received: 19 09 2018
revised: 22 02 2019
accepted: 29 03 2019
pubmed: 25 4 2019
medline: 28 2 2020
entrez: 25 4 2019
Statut: ppublish

Résumé

Some studies have investigated the role of socio-demographic inequalities in the association between screening and survival. However, in France, no study has been conducted to describe the socio-demographic characteristics and survival of women with breast cancer based on their participation to mass screening. The aim of this study was to assess the impact of socio-demographic inequalities on the association between participation in mass screening program and survival of women with breast cancer. Data for 2,244 women aged 50-74 years diagnosed with breast cancer over the period 2008-2010 were obtained from the cancer registry and the screening structure of Gironde. We used the aggregated European Deprivation Index (EDI) to define the deprivation level of women. Net survival rates were estimated with the Pohar-Perme method, with and without correcting for lead-time bias. Survival rates were lower for non-attenders than for screen-detected women (83.8% vs 97.3%, p < 0.0001), even after correcting for lead-time bias. Among the most deprived women, the survival rate was significantly different between non-attenders and screen-detected women (78.1% vs 95.6%, p = 0.0002), suggesting an important effect of mass screening in this group. The introduction of incentive actions in deprived areas could play a key role in the adherence of women to mass screening and in improving their survival in case of a breast cancer diagnosis.

Sections du résumé

BACKGROUND
Some studies have investigated the role of socio-demographic inequalities in the association between screening and survival. However, in France, no study has been conducted to describe the socio-demographic characteristics and survival of women with breast cancer based on their participation to mass screening. The aim of this study was to assess the impact of socio-demographic inequalities on the association between participation in mass screening program and survival of women with breast cancer.
METHODS
Data for 2,244 women aged 50-74 years diagnosed with breast cancer over the period 2008-2010 were obtained from the cancer registry and the screening structure of Gironde. We used the aggregated European Deprivation Index (EDI) to define the deprivation level of women. Net survival rates were estimated with the Pohar-Perme method, with and without correcting for lead-time bias.
RESULTS
Survival rates were lower for non-attenders than for screen-detected women (83.8% vs 97.3%, p < 0.0001), even after correcting for lead-time bias. Among the most deprived women, the survival rate was significantly different between non-attenders and screen-detected women (78.1% vs 95.6%, p = 0.0002), suggesting an important effect of mass screening in this group.
CONCLUSION
The introduction of incentive actions in deprived areas could play a key role in the adherence of women to mass screening and in improving their survival in case of a breast cancer diagnosis.

Identifiants

pubmed: 31015096
pii: S1877-7821(18)30528-9
doi: 10.1016/j.canep.2019.03.016
pii:
doi:

Types de publication

Historical Article Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-155

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Marie Poiseuil (M)

Univ. Bordeaux, Gironde General Cancer Registry, 33000, Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team Epicene, 33000, Bordeaux, France; Univ. Bordeaux, ISPED, 33000, Bordeaux, France. Electronic address: marie.poiseuil@u-bordeaux.fr.

Gaëlle Coureau (G)

Univ. Bordeaux, Gironde General Cancer Registry, 33000, Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team Epicene, 33000, Bordeaux, France; Univ. Bordeaux, ISPED, 33000, Bordeaux, France; Medical Information Service, Public Health Department, Bordeaux University Hospital, 33000, Bordeaux, France. Electronic address: gaelle.coureau@u-bordeaux.fr.

Catherine Payet (C)

Gironde Screening Coordination Structure, 33700, Mérignac, France. Electronic address: catherine.payet@agideca.fr.

Marianne Savès (M)

Univ. Bordeaux, ISPED, 33000, Bordeaux, France; Medical Information Service, Public Health Department, Bordeaux University Hospital, 33000, Bordeaux, France. Electronic address: marianne.saves@u-bordeaux.fr.

Marc Debled (M)

Department of Medical Oncology, Institut Bergonié, 33000, Bordeaux, France. Electronic address: M.Debled@bordeaux.unicancer.fr.

Simone Mathoulin-Pelissier (S)

Inserm, Bordeaux Population Health, Research Center U1219, Team Epicene, 33000, Bordeaux, France; Univ. Bordeaux, ISPED, 33000, Bordeaux, France; Clinical Investigation Center and Clinical Epidemiology, Inserm CIC1401, Institut Bergonié, 33000, Bordeaux, France. Electronic address: simone.pelissier@u-bordeaux.fr.

Brice Amadeo (B)

Univ. Bordeaux, Gironde General Cancer Registry, 33000, Bordeaux, France; Inserm, Bordeaux Population Health, Research Center U1219, Team Epicene, 33000, Bordeaux, France; Univ. Bordeaux, ISPED, 33000, Bordeaux, France. Electronic address: brice.amadeo@u-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH